Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
about
Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors.Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents.The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms.Design, synthesis and potent cytotoxic activity of novel 7-(N-[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives.An overview of quinoline as a privileged scaffold in cancer drug discovery.Camptothecin-7-yl-methanthiole: semisynthesis and biological evaluation.Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.Reconstruction of Alar Nasal Cartilage Defects Using a Tissue Engineering Technique Based on a Combined Use of Autologous Chondrocyte Micrografts and Platelet-rich Plasma: Preliminary Clinical and Instrumental Evaluation.PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.
P2860
Q33420524-FEEFD558-3585-49A1-8E09-1BF967044019Q34036266-1F4EC718-0E46-45AD-AD8B-63223ACC38C9Q34244242-561BAE9D-95D2-4769-8AC0-7A96767BE53CQ38712547-EF7B109A-B058-490E-AC06-15D9A8DC57C4Q39235281-12AB5957-63A8-4254-A8D6-8807F3F67F23Q39255471-C07913E3-D4F8-4E3E-BAE4-CD4B0FC9A85FQ39272645-4D9DF5DB-2AA7-436C-B232-BE79DD54A0C2Q41677092-E408F062-A832-4DEA-9CCC-198CAD989738Q42922896-BD6C964B-0A67-43A0-A716-8E6F51EB1CC3Q47220295-B4D0BFFA-902A-40B0-9B17-9D3B350722F2Q54288262-032125D7-9BC5-40F4-94E3-E5BA4ED6C775
P2860
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@en
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@nl
type
label
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@en
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@nl
prefLabel
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@en
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@nl
P2093
P50
P1476
Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
@en
P2093
Claudio Pisano
Fabiana Fosca Ferrara
Franco Zunino
Gabriella Morini
Graziella Pratesi
Loredana Vesci
Mario Berardino Guglielmi
Paolo Carminati
Rosanna Foderà
Sergio Penco
P304
P356
10.1158/1535-7163.MCT-08-0266
P50
P577
2008-07-01T00:00:00Z